Response to Letter to the editor regarding, “Validity, relevance and interpretation of pharmacovigilance disproportionality analyses”

Abstract

We thank the authors for their interest in our recent manuscript [1]. We find their concerns and justifications valid. However, we wish to emphasise that many of the concerns raised were openly described in our report.

Document Type

Letter to the Editor

Date of Publication

5-1-2023

Volume

170

PubMed ID

36775230

Publication Title

Bone

Publisher

Elsevier

School

School of Medical and Health Sciences

Comments

Rodriguez, A. J., Nerlekar, N., & Ebeling, P. R. (2023). Response to Letter to the editor regarding," Validity, relevance and interpretation of pharmacovigilance disproportionality analyses". Bone, 170, Article 116704. https://doi.org/10.1016/j.bone.2023.116704

Copyright

subscription content

Link to Full Text

Share

 
COinS
 

Link to publisher version (DOI)

10.1016/j.bone.2023.116704

Link to publisher version (DOI)

10.1016/j.bone.2023.116704